Literature DB >> 10697064

A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin.

D Annane1, V Sébille, G Troché, J C Raphaël, P Gajdos, E Bellissant.   

Abstract

CONTEXT: The hypothalamic-pituitary-adrenal axis is a major determinant of the host response to stress. The relationship between its activation and patient outcome is not known.
OBJECTIVE: To evaluate the prognostic value of cortisol levels and a short corticotropin stimulation test in patients with septic shock. DESIGN AND
SETTING: Prospective inception cohort study conducted between October 1991 and September 1995 in 2 teaching hospital adult intensive care units in France. PARTICIPANTS: A total of 189 consecutive patients who met clinical criteria for septic shock. INTERVENTION: A short corticotropin stimulation test was performed in all patients by intravenously injecting 0.25 mg of tetracosactrin; blood samples were taken immediately before the test (T0) and 30 (T30) and 60 (T60) minutes afterward. MAIN OUTCOME MEASURES: Twenty-eight-day mortality as a function of variables collected at the onset of septic shock, including cortisol levels before the corticotropin test and the cortisol response to corticotropin (delta max, defined as the difference between T0 and the highest value between T30 and T60).
RESULTS: The 28-day mortality was 58% (95% confidence interval [CI], 51%-65%) and median time to death was 17 days (95% CI, 14-27 days). In multivariate analysis, independent predictors of death (P < or = .001 for all) were McCabe score greater than 0, organ system failure score greater than 2, arterial lactate level greater than 2.8 mmol/L, ratio of PaO2 to fraction of inspired oxygen no more than 160 mm Hg, cortisol level at T0 greater than 34 microg/dL and delta max no more than 9 microg/dL. Three groups of patient prognoses were identified: good (cortisol level at T0 < or = 34 microg/dL and delta max > 9 microg/dL; 28-day mortality rate, 26%), intermediate (cortisol level at T0 34 microg/dL and delta max < or = 9 microg/dL or cortisol level at T0 > 34 microg/dL and delta max > 9 microg/dL; 28-day mortality rate, 67%), and poor (cortisol level at T0 > 34 microg/dL and delta max < or = 9 microg/dL; 28-day mortality rate, 82%).
CONCLUSION: Our data suggest that a short corticotropin test has a good prognostic value and could be helpful in identifying patients with septic shock at high risk for death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10697064     DOI: 10.1001/jama.283.8.1038

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  173 in total

Review 1.  Hydrocortisone and the reduction of vasopressors in septic shock: therapy or only chart cosmetics?

Authors:  J Briegel
Journal:  Intensive Care Med       Date:  2000-12       Impact factor: 17.440

2.  Association of hyperglycemia, glucocorticoids, and insulin use with morbidity and mortality in the pediatric intensive care unit.

Authors:  Kupper A Wintergerst; Michael B Foster; Janice E Sullivan; Charles R Woods
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

Review 3.  Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis.

Authors:  Djillali Annane; Eric Bellissant; Pierre Edouard Bollaert; Josef Briegel; Didier Keh; Yizhak Kupfer
Journal:  BMJ       Date:  2004-08-02

4.  [Perioperative Addisonian crisis].

Authors:  C Martin; T Steinke; M Bucher; C Raspé
Journal:  Anaesthesist       Date:  2012-06-15       Impact factor: 1.041

5.  Serum cytokines and critical illness-related corticosteroid insufficiency.

Authors:  Yong Soo Kwon; Gee Young Suh; Kyeongman Jeon; So Young Park; So Yeon Lim; Won-Jung Koh; Man Pyo Chung; Hojoong Kim; O Jung Kwon
Journal:  Intensive Care Med       Date:  2010-07-28       Impact factor: 17.440

Review 6.  Adrenal insufficiency: etiology, diagnosis and treatment.

Authors:  Nicola Neary; Lynnette Nieman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-06       Impact factor: 3.243

7.  Initial observations regarding free cortisol quantification logistics among critically ill children.

Authors:  Jerry J Zimmerman; Ruth M Barker; Rhona Jack
Journal:  Intensive Care Med       Date:  2010-08-19       Impact factor: 17.440

8.  Etomidate in sepsis: understanding the dilemma.

Authors:  David J Gagnon; David B Seder
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

9.  Cortisol changes among patients with septic shock and the relationship to ICU and hospital stay.

Authors:  Sergei Goodman; Charles L Sprung; Daniel Ziegler; Yoram G Weiss
Journal:  Intensive Care Med       Date:  2005-09-07       Impact factor: 17.440

Review 10.  Update on adrenal insufficiency in patients with liver cirrhosis.

Authors:  Anca Trifan; Stefan Chiriac; Carol Stanciu
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.